Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haw Par Corporation Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 2.88B | 12.6x | 2.29 | SGD 13.02 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tianjin Zhongxin Pharma Group | Singapore | Healthcare | Pharmaceuticals | SGD 2.20B | 5.5x | 0.07 | SGD 2.86 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyphens Pharma | Singapore | Healthcare | Pharmaceuticals | SGD 89.57M | 9.7x | 0.52 | SGD 0.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Pharmesis International Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 18.39M | 11.6x | 0.05 | SGD 0.58 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IX Biopharma Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 15.98M | -1.8x | -0.31 | SGD 0.02 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suntar Eco-City Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 5.21M | 3.3x | 0 | SGD 0.08 | -23.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |